Intuitive Surgical (NASDAQ: ISRG) controller sells $2.38 million of stock via option exercise

What happened

Fredrik Widman, VP Corporate Controller of Intuitive Surgical Inc (NASDAQ: ISRG), sold 5,448 shares on Oct. 30 for about $2.38 million. The shares came from stock options exercised the same day, and the sale left Widman holding 1,026 shares.

The stock sold at a weighted average of $436.06, in 15 price ranges from $431.64 to $453.60. The largest block, 2,650 shares, went at the low end of that range.

Widman exercised options on 14 separate grants that day. The footnotes describe non-statutory options granted under the 2010 Incentive Award Plan that vest in monthly installments.

The Form 4 says the trades followed a Rule 10b5-1 trading plan that expires Sept. 15, 2027. The reported shares are held directly.

Key numbers

Metric	Latest	Change	Source
Shares sold	5,448 shares		SEC Form 4
Weighted average sale price	$436.06		SEC Form 4
Total proceeds	$2.38 million		SEC Form 4
Shares held after the sale	1,026 shares		SEC Form 4
Shares sold as a share of holding before the sale	84.2%		Calculated from SEC Form 4

Read more: Intuitive Surgical (ISRG) company research

Why it matters

The sale took out most of the position. By OptimistFi's calculation, the 5,448 shares were 84.2% of the 6,474 shares Widman held after the option exercises and just before the sale.

The percentage covers shares only. Several option grants still show unexercised balances in the form's derivative table, so it is not a measure of Widman's total equity exposure. The options carried exercise prices from $79.64 to $347.42, all below the weighted average sale price.

Because the shares came from options exercised the same day under a prearranged plan, the sale may reflect routine monetization rather than a fresh signal about the business.

OptimistFi has argued that Intuitive turns system sales into recurring revenue from instruments, services and software, and that EPS growth depends on a growing installed base. One officer's plan-based sale does not test those drivers, so the filing leaves the investment case unchanged.

Stock perps: every US stock that trades as a perpetual future, by leverage, live

What's next

Intuitive's next quarterly report is the next test of the investment case. Growth in recurring revenue from instruments, services and software would support OptimistFi's view, while a slowdown in that revenue or in the installed base would weaken it.

More from OptimistFi

• ISRG stock: research and coverage of Intuitive Surgical
• Stock research on every company OptimistFi covers

From OptimistFi Perps